妊娠合并重型肝炎行子宫切除术指征探讨

张 媛;范建辉;吴玲玲;周水生;侯红瑛

新医学 ›› 2010, Vol. 41 ›› Issue (12) : 778.

新医学 ›› 2010, Vol. 41 ›› Issue (12) : 778.
论著

妊娠合并重型肝炎行子宫切除术指征探讨

  • 张 媛;范建辉;吴玲玲;周水生;侯红瑛
作者信息 +
文章历史 +

摘要

目的:探讨妊娠合并重型肝炎孕妇行子宫切除术的指征。方法:选择62例妊娠合并重型肝炎患者,根据患者入院时凝血酶原活动度(PTA) ≤30%或>30%、总胆红素<342 μmol/L或≥342 μmol/L、是否酶-胆分离、白细胞计数分组,分别对各组中行子宫切除术及未行子宫切除术的患者的预后进行比较,分析妊娠合并重型肝炎行子宫切除术的指征。结果:当PTA≤30%或白细胞≥20×109/L时行子宫切除术者与未行子宫切除术者预后比较差异有统计学意义(P<0.05),其余指标分组间是否行子宫切除术其预后比较差异无统计学意义(P>0.05)。结论:对于妊娠合并重型肝炎患者,当PTA≤30%和(或)白细胞计数≥20×109/L时,应考虑行子宫切除术。

Abstract

Objective: To explore the indication of hysterectomy on the pregnancy complicating hepatitis gravis.Methods: Sixty two cases of hepatitis gravis patients during pregnancy from 2003 to 2009 were retrospectively analyzed.These patients were grouped according to the criteria prothrobin activity(PTA)≤30% or >30%, serum total bilirubin (TBIL) <342 μmol/L or ≥342 μmol/L, white blood cell count(WBC)<20×109/L or ≥20×109/L, or the occurrence of bilirubin separation.In each group, clinical cure rate were compared using fisher’s exact test between hysterectomy and not-hysterectomy patients. Results: When PTA≤30% or WBC≥20×109/L, the clinical cure rate exist significant different between hysterectomy group and not-hysterectomy group(P<0.05). No statistical difference between hysterectomy group and not-hysterectomy group were found in the other groups(P>0.05).Conclusion: When PTA≤30% and(or) WBC≥20×109/L,hysterectomy in the pregnancy complicating hepatitis gravis should be considered.

引用本文

导出引用
张 媛;范建辉;吴玲玲;周水生;侯红瑛. 妊娠合并重型肝炎行子宫切除术指征探讨[J]. 新医学, 2010, 41(12): 778

589

Accesses

0

Citation

Detail

段落导航
相关文章

/